These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18601955)

  • 1. Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo.
    Kim SM; Lee KN; Park JY; Ko YJ; Joo YS; Kim HS; Park JH
    Antiviral Res; 2008 Nov; 80(2):178-84. PubMed ID: 18601955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.
    Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z
    J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus.
    Kim SM; Lee KN; Lee SJ; Ko YJ; Lee HS; Kweon CH; Kim HS; Park JH
    Antiviral Res; 2010 Sep; 87(3):307-17. PubMed ID: 20561543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-vectored shRNAs targeted to the highly conserved regions of VP1 and 2B in tandem inhibits replication of foot-and-mouth disease virus both in vitro and in vivo.
    Xu YF; Shen HY; Zhao MQ; Chen LJ; Li YG; Liao M; Jia JT; Lv YR; Yi L; Chen JD
    J Virol Methods; 2012 Apr; 181(1):51-8. PubMed ID: 22327142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
    Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
    J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome.
    Liu M; Chen W; Ni Z; Yan W; Fei L; Jiao Y; Zhang J; Du Q; Wei X; Chen J; Liu Y; Zheng Z
    Virology; 2005 May; 336(1):51-9. PubMed ID: 15866070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice.
    Chen W; Yan W; Du Q; Fei L; Liu M; Ni Z; Sheng Z; Zheng Z
    J Virol; 2004 Jul; 78(13):6900-7. PubMed ID: 15194766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
    Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
    Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid control of foot-and-mouth disease outbreaks: is RNAi a possible solution?
    Grubman MJ; de los Santos T
    Trends Immunol; 2005 Feb; 26(2):65-8. PubMed ID: 15668119
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus.
    Kim SM; Kim SK; Park JH; Lee KN; Ko YJ; Lee HS; Seo MG; Shin YK; Kim B
    Antiviral Res; 2014 Apr; 104():52-8. PubMed ID: 24485895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus.
    de los Santos T; Wu Q; de Avila Botton S; Grubman MJ
    Virology; 2005 May; 335(2):222-31. PubMed ID: 15840521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.
    Pacheco JM; Brum MC; Moraes MP; Golde WT; Grubman MJ
    Virology; 2005 Jul; 337(2):205-9. PubMed ID: 15893355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mouse model integrating siRNA targeting the foot and mouth disease virus.
    Pengyan W; Jianjun J; Ning L; Jinliang S; Yan R; Chuangfu C; Zhiru G
    Antiviral Res; 2010 Aug; 87(2):265-8. PubMed ID: 20176056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA immunization can protect mice against foot-and-mouth disease virus.
    Pulido MR; Sobrino F; Borrego B; Sáiz M
    Antiviral Res; 2010 Mar; 85(3):556-8. PubMed ID: 20005905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
    Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
    J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus.
    Goris N; De Palma A; Toussaint JF; Musch I; Neyts J; De Clercq K
    Antiviral Res; 2007 Mar; 73(3):161-8. PubMed ID: 17055073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.